Reprint

Gastrointestinal Tract Disorders

Edited by
April 2022
236 pages
  • ISBN978-3-0365-3715-3 (Hardback)
  • ISBN978-3-0365-3716-0 (PDF)

This book is a reprint of the Special Issue Gastrointestinal Tract Disorders that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

Gastrointestinal tract disorders are a wide group of diseases involving both the gastrointestinal tube (esophagus, stomach, small and large intestine) and related organs (liver, pancreas, and gallbladder). These dysfunctions may differ by site, etiology, and severity, going from simple malfunctions to mere diseases. Because of their variety and heterogeneity, gastrointestinal disorders can affect many people and are widespread throughout the population. Therefore, scientific research in this area is facing a great challenge. Better knowledge of gastrointestinal disorders in terms of their pathophysiology, clinical features, and possible complications is necessary for the development of new diagnostic methods and therapeutic strategies. During the last several decades, some scientific developments have already been made, giving more opportunities to these patients. However, much remains to be discovered and to be done to help physicians in their everyday work and to give patients a better prognosis.

The present Special Issue aims to highlight recent advances in gastrointestinal tract disorders, focusing on their diagnostic and therapeutic path, evolution, and complications.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
Crohn’s disease; ulcerative colitis; biologics; anemia; gastroesophageal reflux; cough; asthma; laryngo-pharyngeal reflux; chest pain; tooth erosions; inflammatory bowel diseases; sleep disorders; sleep medicine; PPI; diverticulosis; diverticulitis; risk factors; Marfan’s syndrome; diverticula; abdominal symptoms; ultrasound; infant; food allergy; fecal biomarkers; tumor necrosis factor α; eosinophil derived neurotoxin; calprotectin; Emorsan®Gel; hemorrhoidal disease; hemorrhoidectomy; pain; wound healing; chronic idiopathic constipation; constipation; irritable bowel syndrome; pathophysiology; primary care; medical students; public health; social media; dietary habit; pandemic; dyspepsia; diabetes; gastroparesis; inflammatory bowel disease; SCORE; carotid plaques; cardiovascular risk; dyssynergic defecation; constipation; slow transit constipation; motility; colonic transit; anorectal manometry; gastrointestinal disorders; endoscopic vacuum therapy; etiology; transmural defect; upper gastrointestinal tract; Helicobacter pylori; eradication; antibiotic resistance; tailored; empirical; gastrointestinal bleeding; new oral anticoagulants; vitamin K antagonist; rebleeding; Helicobacter pylori; chronic gastritis; peptic ulcer disease; gastric cancer; MALT-lymphoma; therapy; vaccines; DA-9701; diabetic mouse model; functional dyspepsia; diabetic gastroparesis; STZ; gastrointestinal motility; human leukocyte antigen; celiac disease; inflammatory bowel disease; autoimmune hepatitis; primary sclerosing cholangitis; primary biliary cholangitis; autoimmune pancreatitis; IgG4-related sclerosing cholangitis; IgG4-related hepatopathy; n/a